SUBSCRIBE
SUBSCRIBE

TG Therapeutics, Inc.

NEWS
Pharm Country
TG Therapeutics to Participate in the 40th Annual J.P. Morgan Healthcare Conference
January 5, 2022
 · 
1 min read
Pharm Country
TG Therapeutics Expands Term Loan Facility With Hercules Capital to $200 Million$70 million funded at closing
January 4, 2022
 · 
6 min read
Drug Development
Clinical Catch-Up: December 11-17
December 17, 2021
 · 
16 min read
 · 
Mark Terry
Drug Development
TG Therapeutics Announces Data from the UNITY-CLL Phase 3 Trial Presented at the 63rd American Society of Hematology (ASH) Annual Meeting
December 14, 2021
 · 
17 min read
Pharm Country
TG Therapeutics Announces FDA Acceptance of Biologics License Application for Ublituximab as a Treatment for Patients with Relapsing Forms of Multiple Sclerosis
December 14, 2021
 · 
7 min read
Pharm Country
TG Therapeutics Announces Data Presentations at the 63rd American Society of Hematology (ASH) Annual Meeting
December 13, 2021
 · 
14 min read
Pharm Country
TG Therapeutics Recaps Schedule of Data Presentations at the Upcoming 63rd American Society of Hematology (ASH) Annual Meeting
December 10, 2021
 · 
6 min read
Policy
TG Therapeutics Provides Regulatory Update Company to host conference call today, Tuesday, November 30, 2021 at 8:30 AM ET
November 30, 2021
 · 
16 min read
Pharm Country
TG Therapeutics to Participate in the Jefferies London Healthcare ConferenceFireside chat available for on demand download at 5:00 PM GMT/ 3:00 AM ET on Thursday November 18, 2021
November 15, 2021
 · 
1 min read
Pharm Country
TG Therapeutics to Participate in the B. Riley Securities Fall 2021 Growth Biotech Best Ideas Virtual Series Fireside chat scheduled for 12:00 PM ET on Thursday November 11, 2021
November 9, 2021
 · 
1 min read
Pharm Country
TG Therapeutics Highlights Data Selected for Presentation at the 63rd American Society of Hematology (ASH) Annual Meeting
November 4, 2021
 · 
7 min read
Business
TG Therapeutics Provides Business Update and Reports Third Quarter 2021 Financial Results
November 4, 2021
 · 
13 min read
Business
TG Therapeutics to Host Conference Call on Third Quarter 2021 Financial Results and Business UpdateConference call to be held Thursday, November 4, 2021 at 8:30 AM ET
November 1, 2021
 · 
1 min read
BioForest
Clinical Catch-Up: October 11-15
October 15, 2021
 · 
11 min read
 · 
Mark Terry
Drug Development
TG Therapeutics Announces Data for Ublituximab in Multiple Sclerosis Presented at the 37th Congress of the European Committee for Treatment and Research in Multiple Sclerosis
October 14, 2021
 · 
11 min read
Pharm Country
TG Therapeutics Submits Biologics License Application to the U.S. Food and Drug Administration for Ublituximab as a Treatment for Patients with Relapsing Forms of Multiple Sclerosis
September 30, 2021
 · 
7 min read
Load More
AWARDS
  • 2026 - Best Places to Work - Badge (1).png
JOBS